NUWE NUWELLIS INC

Nuwellis, Inc. To Announce Third Quarter 2022 Financial Results on November 8, 2022

Nuwellis, Inc. To Announce Third Quarter 2022 Financial Results on November 8, 2022

MINNEAPOLIS, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its third quarter 2022 financial results will be released on Tuesday, November 8, 2022. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview.

To access the live webcast, please visit the Investors page of the Nuwellis website at . Alternatively, you may access the live conference call by dialing 1-844-825-9789 (U.S) or 1-412-317-5180 (international) and using the conference ID: 10172214. An audio archive of the webcast will be available following the call on the Investors page at .

About Nuwellis 

Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly-owned subsidiary in Ireland. 

Investor Contacts:

Lynn Blake

Chief Financial Officer, Nuwellis, Inc.

Vivian Cervantes

Gilmartin Group LLC

Media Contact:

Sarah Lundberg

Health+Commerce



EN
19/10/2022

Underlying

NUWENUWELLIS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NUWELLIS INC

 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Stra...

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy Appointment Strengthens Clinical Leadership in Precision Fluid Management and Acute Kidney Injury MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Stuart L. Goldstein, MD, FASN as Director of Clinical Strategy. Dr. Goldstein is internationally recognized as a pioneer in pediatric nephrology and criti...

March 5, 2026 1 EN
 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of ...

Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of David A. McDonald and Martin J. Emerson to its Board of Directors, effective February 24, 2026. The appointments strengthen the Company’s board with complementary expertise in public company leadership, capital markets, and medical device commercialization. “These appointments reflect our c...

February 26, 2026 1 EN
 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial R...

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will release financial results for the fourth quarter and full year 2025 on March 10, 2026. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of th...

February 24, 2026 1 EN
 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Nuwellis Appoints Carisa Schultz as Chief Financial Officer Schultz brings public company healthcare finance and medical technology experience to support Nuwellis’ next phase of growth MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at ...

January 30, 2026 1 EN
 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis Announces $5 Million Private Placement and Warrant Inducement...

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced that it has entered into a securities purchase agreement with an institutional and accredited investor (the “Investor”) for the purchase and sale of 994,537 shares (the “Shares”) of the Company’s common stock, $0.0001 par value (the “Common Stock”) or (pre-funde...

January 29, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch